INVO Fertility, Inc. Debt Instrument, Convertible, Conversion Price
INVO Fertility, Inc. (IVF) had Debt Instrument, Convertible, Conversion Price of $12.00 per share as of 2024-03-31, per its 10-Q filed 2024-05-15.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2024-11-19
- 2024-03-31: Debt Instrument, Convertible, Conversion Price $12.00.
- 2023-12-31: Debt Instrument, Convertible, Conversion Price $12.00.
- 2023-09-30: Debt Instrument, Convertible, Conversion Price $12.00.
- 2023-06-30: Debt Instrument, Convertible, Conversion Price $12.00.
| Period end | Debt Instrument, Convertible, Conversion Price | Debt Instrument, Convertible, Conversion Price as first filed |
|---|---|---|
| 2024-03-31 | $12.00 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $12.00 10-K/A · filed 2024-11-19 | |
| 2023-09-30 | $12.00 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $12.00 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $12.00 10-Q/A · filed 2024-11-19 | $0.60 10-Q · filed 2023-05-15 |
| 2022-12-31 | $0.50 10-K · filed 2023-04-17 | |
| 2018-05-31 | $0.20 10-Q · filed 2019-05-15 | |
| 2011-12-31 | $0.96 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |